Prostate Cancer Market Research
Incidences of cancer afflictions have rapidly increased in recent years, while efforts are still underway to find an effective treatment for this disease.
Research reveals that the prostate cancer market is expected to show high growth till 2015. As per research estimates, the global prostate cancer market was valued at $5.4 billion in 2009 and is forecast to further increase at a compound annual growth rate (CAGR) of 6% to reach $7.8 billion by 2015. This high growth forecast is believed to be mainly due to the strong pipeline landscape with innovative drugs and also owing to the high population growth.
The Prostate Cancer drug therapy market research report provides insight into the pipeline status of prostate cancer therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the prostate cancer drugs & therapy market.